Section Arrow
Quote
CNTB.NASDAQ
- Connect Biopharma Holdings Limited
Quotes are at least 15-min delayed:2025/03/28 05:26 EDT
Last
 0.76
-0.02 (-2.56%)
Day High 
0.8439 
Prev. Close
0.78 
1-M High
0.94 
Volume 
17.07K 
Bid
0.7
Ask
0.9
Day Low
0.76 
Open
0.8165 
1-M Low
0.7777 
Market Cap 
43.10M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.82 
20-SMA 0.83 
50-SMA 0.91 
52-W High 2.66 
52-W Low 0.76 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.39/-0.38
Enterprise Value
43.28M
Balance Sheet
Book Value Per Share
2.00
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Created with Highstock 5.0.121-min Chart12:0015:300.750.7750.80.8250.85etnet.com.hk@copyright
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
OCEAOcean Biomedical0.078-0.0057-6.81%-- 
DRMADermata Therapeutics Inc.1.42+0.07+5.19%-- 
ONCOOnconetix Inc0.1077+0.0017+1.60%-- 
RGLSRegulus Therapeutics1.5+0.21+16.28%-- 
NKTXNkarta1.97+0.6+43.80%-- 
Quotes are at least 15-min delayed：2025/03/28 05:26 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.